文献速递系统性红斑狼疮

基于人工智能的在线症状评估工具用于系统性红斑狼疮诊断:患者视角

Artificial Intelligence-Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-05-15

患者认为此类工具可提升症状意识、促进就医和医患沟通,但也担忧其因SLE复杂性而效用有限、受医疗可及性和医生接受度制约、可能传播错误信息及数据隐私问题。

要点

  • SLE患者认为AI症状评估工具有助症状觉察、就医促进和医患沟通
  • 患者担忧工具因SLE复杂性而效用有限且可能提供错误信息
  • 医疗可及性、医生接受度和数据隐私是患者关注的结构性障碍

核心结论

  • SLE患者认为AI在线症状评估工具在应对复杂疾病诊断延迟方面兼具益处与局限。

研究设计与样本

  • 邀请SLE研究队列中的成人参与60至90分钟虚拟焦点小组,由培训 moderators 使用标准化问题引导,并演示AI症状检查应用,采用归纳主题分析编码转录并生成主题。

主要发现

  • 主题涉及诊断旅程(包括及时诊断障碍)、对在线健康工具的熟悉度、感知益处及对AI症状评估工具的担忧。
  • 最突出的益处为症状意识和验证、鼓励就医以及促进医疗讨论。
  • 患者表达了诸多担忧,包括因SLE复杂性导致效用有限、医疗可及性和医生接受度相关的结构性限制、错误信息的可能性以及轻微的数据隐私问题。

临床怎么用

  • 临床中可借助AI在线症状评估工具提升SLE患者症状意识并促进就医和医患沟通。
  • 需向患者说明此类工具在复杂疾病中的效用局限和潜在错误信息风险。

局限性

  • 样本来自单一SLE研究队列,平均病程19.1(SD 8.8)年,多数为女性且50%为白人,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)-based online symptom assessment tools, and the potential of these tools to address diagnostic barriers. METHODS: Adults from our SLE research cohort were invited to participate in 60- to 90-minute virtual focus groups concerning their experiences obtaining an SLE diagnosis and perspectives on patient-facing online symptom assessment tools to assist/expedite diagnosis. Sessions were facilitated by trained moderators using standardized questions and included a demonstration of an AI-based symptom checker application. An inductive thematic data analysis was used to code the transcripts and generate themes/subthemes. RESULTS: Twenty-four patients participated in four focus groups (two in English, two in French). The mean age was 50.4 (SD 9.7) years, and the mean duration since SLE diagnosis was 19.1 (SD 8.8) years. Most (92%) participants were female, and 50% were White, with the remainder being Asian, Black, Hispanic, or Indigenous. Themes concerned the following: (1) diagnostic journeys, including barriers to timely SLE diagnosis; (2) familiarity with online health tools; (3) perceived benefits; and (4) concerns regarding AI symptom assessment tools. The most prominent benefits identified were symptom awareness and validation, encouragement to seek care, and facilitation of health care discussions. Numerous concerns were expressed, including narrow usefulness given SLE complexity, structural limitations relating to health care access and provider receptiveness, the possibility of misinformation, and minor issues of data privacy. CONCLUSION: This article provides SLE patient perspectives on the benefits and limitations of AI-based online symptom assessment tools in addressing diagnostic delays of a complex diagnostic condition.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Stein OA, Lee JLF, Vinet E, et al. Artificial Intelligence-Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives. Arthritis Care Res (Hoboken). 2026. PMID: 42138311. doi:10.1002/acr.80087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。